Dr. Mark Shen performed the surgery using a new system called “Affera Mapping and Ablation” to treat atrial fibrillation.

Dr. Mark Shen performed the surgery using a new system called “Affera Mapping and Ablation” to treat atrial fibrillation.

As cardiology accelerates its shift into the outpatient setting, ASCs are confronting new opportunities alongside mounting business, reimbursement and operational pressures. Here are five advances ...

No significant difference seen in composite outcome of stroke, systemic embolism, new covert embolic stroke.

Medtronic achieved global revenue of almost $9bn in Q2 FY26, with its cardiovascular portfolio contributing $3.44bn.

Medtronic ( ($MDT) ) has released its Q2 earnings. Here is a breakdown of the information Medtronic presented to its investors. Medtronic plc, ...

The future of heart health is on showcase here in the Quad Cities. Two medical ‘firsts’ were announced last week. A new tool ...

The META-AF trial found fewer recurrences of atrial arrhythmias, a benefit unexplained by weight loss or glycemic control.

Medtronic leaders Geoff Martha, Thierry Piéton and Laura Mauri offer their thoughts on M&A, R&D, RDN, PFA, Hugo and other ...

As part of the collaboration, Volta Medical's latest AI solution, the AF-Xplorer II system, has been integrated with GE ...

Pulsed field ablation sales grew by more than 300% in the second quarter for the company’s fiscal year 2026, amid mounting ...

Get Q2 2026 Medtronic earnings call highlights—raised revenue/EPS guidance, robust growth in cardiac ablation, and new product launches.